New drug combo shows promise for bladder cancer patients who Can't take chemo
NCT ID NCT02845323
First seen Apr 07, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study tests two immunotherapy drugs, nivolumab and urelumab, given before bladder removal surgery for patients with muscle-invasive bladder cancer who cannot or choose not to have chemotherapy. The goal is to see if adding urelumab boosts the immune response against the tumor. The study involves 15 participants and focuses on safety and tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21205, United States
-
UCLA Institute of Urologic Oncology
Los Angeles, California, 90095, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Colorado Cancer Center
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.